1. Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study;Borja-Tabora;BMC Infect Dis,2013
2. Guillain-Barré syndrome among recipients of Menactra® meningococcal conjugate vaccine-United States, June-July 2005;CDC (Centers for Disease Control and Prevention);MMWR,2005
3. Updated recommendations for use of meningococcal conjugate vaccines- Advisory committee on immunization practices (ACIP), 2010;CDC (Centers for Disease Control and Prevention);MMWR,2011
4. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Cohn;MMWR,2013